It is our aim to assist national kidney cancer patient organizations in helping patients and their families worldwide to obtain the information necessary to play an active role in the management of their kidney cancer and to gain a better awareness of what they can expect from their treatment and care.
This charter was developed in April 2014 in Amsterdam, The Netherlands, at a meeting of kidney cancer patient advocates from diverse geographic regions convened by the IKCC. For a period of 4 years, the IKCC has used web-based search engines and personal networks to contact all patient organizations globally with a stated interest in kidney cancer. In several countries, general cancer or kidney organizations only have a kidney cancer chapter or contact person; however, many countries have independent organizations dedicated specifically to kidney cancer patient support, including Canada, the USA, the UK, The Netherlands, Germany and Ghana. More than 40 organizations have been contacted by the IKCC and invited to attend annual meetings. The 34 patient group representatives present at the Amsterdam meeting, coming from 20 countries spread over six continents, identified the hurdles met by kidney cancer patients worldwide and outlined the universal standards of care that patients should expect, with the goal of enabling patients to become active, informed and empowered participants at every stage of their treatment. The charter contends that the current situation could be improved if those involved in the care and treatment of patients adopted the principles outlined in the charter on a global scale. This charter is entirely driven by patient organizations and is intended to underscore the global need for equity of care and access to expertise.
Collectively, the global kidney cancer community declares that patients have the following rights:
- Timely investigation and accurate diagnosis by medical experts with experience in treating
- Patient-oriented information and education concerning all treatments including quality of
life, side-effect management, pain control, and palliative care;
- Access to optimal, current evidence-based treatment as suggested by a multidisciplinary
team of medical professionals possessing specialist knowledge about kidney cancer;
- Regular follow-up care concordant with national and/or international guidelines including
appropriate and culturally sensitive psychosocial support;
- Access to medical records, including pathology and imaging reports, if requested;
- Provision of information on all available support systems, including patient support tools
and local patient support and advocacy organizations;
- An active role in decision-making concerning the management of their kidney cancer (e.g.
patients should be offered a choice, whenever possible, in the surgical and medical
management of their kidney cancer);
- Information regarding the availability of clinical trials in their country/region;
- Recognition that kidney cancer can have long-term effects, including heart disease and
kidney function insufficiency. Patients should be provided with survivorship information,
including medical and lifestyle recommendations; and
- Recognition that up to 10% of all kidney cancer tumours are hereditary in nature as part
of familial syndromes, and that these patients require specialized and coordinated care over
their entire lifetime.
The charter was signed by the participants of the
4th IKCC Annual Conference EXPANDING CIRCLES in Amsterdam.
Acknowledgments: We are grateful to Julia Black and Markus Wartenberg for managerial support. Travel and accommodation for all attendees to the Amsterdam meeting were supported by equal funds from Bayer, GlaxoSmithKline, Pfizer and Novartis. There are no conflicts of interest.
Click here for the Amsterdam Patient Charter for Global Kidney Cancer Care (as pdf-download)
We are thrilled that the leading urological journal European Urology (impact factor 12.5) has accepted our “Amsterdam Patient Charter for Global Kidney Cancer Care” for publication. European Urology Journal
Please click the link below for a copy of the Charter translated in the following languages:
How the charter has been developed
One direct outcome of our conference in Amsterdam is our international patient charter for kidney cancer care. Following the conference in April 2014, we asked the 34 groups present to prioritise 10 statements according to the needs of kidney cancer patients in their own country. The results of the survey were drafted into a Patient Charter.